212 related articles for article (PubMed ID: 33053366)
1. Vincristine-induced peripheral neuropathy: A mini-review.
Li GZ; Hu YH; Li DY; Zhang Y; Guo HL; Li YM; Chen F; Xu J
Neurotoxicology; 2020 Dec; 81():161-171. PubMed ID: 33053366
[TBL] [Abstract][Full Text] [Related]
2. Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia.
Tay CG; Lee VWM; Ong LC; Goh KJ; Ariffin H; Fong CY
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28139029
[TBL] [Abstract][Full Text] [Related]
3. Vincristine-induced peripheral neuropathy in children with cancer: A systematic review.
van de Velde ME; Kaspers GL; Abbink FCH; Wilhelm AJ; Ket JCF; van den Berg MH
Crit Rev Oncol Hematol; 2017 Jun; 114():114-130. PubMed ID: 28477739
[TBL] [Abstract][Full Text] [Related]
4. Genetic factors influencing the development of vincristine-induced neurotoxicity.
Pozzi E; Fumagalli G; Chiorazzi A; Canta A; Cavaletti G
Expert Opin Drug Metab Toxicol; 2021 Feb; 17(2):215-226. PubMed ID: 33283553
[No Abstract] [Full Text] [Related]
5. Obesity as a Potential Risk Factor for Vincristine-induced Peripheral Neuropathy.
Sajdyk TJ; Boyle FA; Foran KS; Tong Y; Pandya P; Smith EML; Ho RH; Wells E; Renbarger JL
J Pediatr Hematol Oncol; 2020 Oct; 42(7):e637-e640. PubMed ID: 31634238
[TBL] [Abstract][Full Text] [Related]
6. Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.
Lavoie Smith EM; Li L; Chiang C; Thomas K; Hutchinson RJ; Wells EM; Ho RH; Skiles J; Chakraborty A; Bridges CM; Renbarger J
J Peripher Nerv Syst; 2015 Mar; 20(1):37-46. PubMed ID: 25977177
[TBL] [Abstract][Full Text] [Related]
7. Vincristine-Induced Peripheral Neuropathy (VIPN) in Pediatric Tumors: Mechanisms, Risk Factors, Strategies of Prevention and Treatment.
Triarico S; Romano A; Attinà G; Capozza MA; Maurizi P; Mastrangelo S; Ruggiero A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923421
[TBL] [Abstract][Full Text] [Related]
8. Prospective assessment of vincristine-induced peripheral neuropathy in paediatric acute lymphoblastic leukemia.
Li T; Kandula T; Cohn RJ; Kiernan MC; Park SB; Farrar MA
Clin Neurophysiol; 2023 Oct; 154():157-168. PubMed ID: 37633123
[TBL] [Abstract][Full Text] [Related]
9. RISK FACTORS OF VINCRISTINE-INDUCED PERIPHERAL NEUROPATHY IN ACUTE LYMPHOBLASTIC LEUKAEMIA CHILDREN.
Tunjungsari DA; Gunawan PI; Ugrasena IDG
J Med Invest; 2021; 68(3.4):232-237. PubMed ID: 34759136
[TBL] [Abstract][Full Text] [Related]
10. Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening.
Verstappen CC; Koeppen S; Heimans JJ; Huijgens PC; Scheulen ME; Strumberg D; Kiburg B; Postma TJ
Neurology; 2005 Mar; 64(6):1076-7. PubMed ID: 15781834
[TBL] [Abstract][Full Text] [Related]
11. Fluoroquinolone prophylaxis does not increase risk of neuropathy in children with acute lymphoblastic leukemia.
Karol SE; Sun Y; Tang L; Pui CH; Ferrolino J; Allison KJ; Cross SJ; Evans WE; Crews KR; Jeha S; Wolf J
Cancer Med; 2020 Sep; 9(18):6550-6555. PubMed ID: 32710497
[TBL] [Abstract][Full Text] [Related]
12. Effect of pyridoxine plus pyridostigmine treatment on vincristine-induced peripheral neuropathy in pediatric patients with acute lymphoblastic leukemia: a single-center experience.
Aydin Köker S; Gözmen S; Demirağ B; Ünalp A; Karapinar TH; Oymak Y; Gürbüz G; Öner Eİ; Vergin RC
Neurol Sci; 2021 Sep; 42(9):3681-3686. PubMed ID: 33439396
[TBL] [Abstract][Full Text] [Related]
13. [A cohort study of vincristine-induced peripheral neuropathy in children].
Li C; Jin J; Huang J; Yang XY; Li Y; Yan YY; Yang C
Zhongguo Dang Dai Er Ke Za Zhi; 2023 May; 25(5):470-475. PubMed ID: 37272172
[TBL] [Abstract][Full Text] [Related]
14. Measuring vincristine-induced peripheral neuropathy in children with cancer: validation of the Dutch pediatric-modified Total Neuropathy Score.
Schouten SM; van de Velde ME; Kaspers GJL; Mokkink LB; van der Sluis IM; van den Bos C; Hartman A; Abbink FCH; van den Berg MH
Support Care Cancer; 2020 Jun; 28(6):2867-2873. PubMed ID: 31732853
[TBL] [Abstract][Full Text] [Related]
15. Vincristine-Induced Peripheral Neuropathy in Childhood Acute Lymphoblastic Leukemia: Genetic Variation as a Potential Risk Factor.
Yang QY; Hu YH; Guo HL; Xia Y; Zhang Y; Fang WR; Li YM; Xu J; Chen F; Wang YR; Wang TF
Front Pharmacol; 2021; 12():771487. PubMed ID: 34955843
[TBL] [Abstract][Full Text] [Related]
16. The association between vincristine-induced peripheral neuropathy and health-related quality of life in children with cancer.
van de Velde ME; van den Berg MH; Kaspers GJL; Abbink FCH; Twisk JWR; van der Sluis IM; van den Bos C; van den Heuvel-Eibrink MM; Segers H; Chantrain C; van der Werff Ten Bosch J; Willems L; van Litsenburg RRL
Cancer Med; 2021 Nov; 10(22):8172-8181. PubMed ID: 34725942
[TBL] [Abstract][Full Text] [Related]
17. Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia.
Egbelakin A; Ferguson MJ; MacGill EA; Lehmann AS; Topletz AR; Quinney SK; Li L; McCammack KC; Hall SD; Renbarger JL
Pediatr Blood Cancer; 2011 Mar; 56(3):361-7. PubMed ID: 21225912
[TBL] [Abstract][Full Text] [Related]
18. CYP3A5 genotype and its impact on vincristine pharmacokinetics and development of neuropathy in Kenyan children with cancer.
Skiles JL; Chiang C; Li CH; Martin S; Smith EL; Olbara G; Jones DR; Vik TA; Mostert S; Abbink F; Kaspers GJ; Li L; Njuguna F; Sajdyk TJ; Renbarger JL
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29115708
[TBL] [Abstract][Full Text] [Related]
19. Sexual dimorphism for protein kinase c epsilon signaling in a rat model of vincristine-induced painful peripheral neuropathy.
Joseph EK; Levine JD
Neuroscience; 2003; 119(3):831-8. PubMed ID: 12809704
[TBL] [Abstract][Full Text] [Related]
20. Clinical and electrophysiological studies in vincristine induced neuropathy.
Pal PK
Electromyogr Clin Neurophysiol; 1999 Sep; 39(6):323-30. PubMed ID: 10499201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
